Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 11/20 | 0.72 |
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.56 |
| ▸ | PPARG | P37231 | 1/20 | 0.54 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.54 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.53 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.50 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8698288 | 0.88 | CCR2 (0.69) | CCR2GPR35PPARGSERPINE1PLA2G10 | |
| SCHEMBL5378162 | 0.85 | CCR2 (1.00) | CCR2GPR35PLA2G10NOD2NOD1 | |
| SCHEMBL8697141 | 0.84 | CCR2 (0.67) | CCR2GPR35PPARGSERPINE1NOD2 | |
| SCHEMBL8697927 | 0.84 | CCR2 (0.67) | CCR2GPR35PPARGSERPINE1PLA2G10 | |
| SCHEMBL3961949 | 0.82 | CCR2 (1.00) | CCR2GPR35 | |
| SCHEMBL29845455 | 0.81 | CCR2 (0.81) | CCR2GPR35PLA2G10NOD2NOD1 | |
| SCHEMBL7008246 | 0.81 | CCR2 (0.81) | CCR2GPR35PLA2G10NOD2NOD1 | |
| SCHEMBL8696653 | 0.81 | PPARG (0.64) | CCR2PPARGSERPINE1 | |
| SCHEMBL27513366 | 0.80 | CCR2 (0.72) | CCR2GPR35PLA2G10NOD2NOD1 | |
| SCHEMBL8697036 | 0.79 | CCR2 (0.60) | CCR2PPARGSERPINE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5767133-A | Secondary amines as antidiabetic and antiobesity agents | PFIZER INC. (US) | 1998-06-16 | — | — | US | disclosed |